Comparison of effect sizes between the efficacy of treatment with... | Download Scientific Diagram
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis | NEJM
HUMIRA (adalimumab), Abbott Laboratories - Package Insert
HUMIRA (adalimumab) Dermatology HCP Site
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet's disease: results from a large real-world observational study
Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years - ACR Meeting Abstracts
Humira 40 mg/0.4 ml Pre-filled Syringe and Pre-filled Pen (Great Britain) - Summary of Product Characteristics (SmPC) - (emc)
Humira, INN - adalimumab
HUMIRA® (adalimumab) for Rheumatoid Arthritis (RA)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis - Gastroenterology
Humira, INN - adalimumab
Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial | PLOS ONE
PDF) A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III - Ophthalmology
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study - The Lancet
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - ScienceDirect
Adalimumab: a review of the reference product and biosimilars | BS
Frontiers | Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial
Clinical, Functional, and Radiographic Benefits of Longterm Adalimumab Plus Methotrexate: Final 10-year Data in Longstanding Rheumatoid Arthritis | The Journal of Rheumatology
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease - The Journal of Pediatrics
